Processing your request

please wait...

Case Page


Case Status:    ONGOING    
On or around 02/14/2020 (Date of last review)

Filing Date: November 14, 2017

According to the law firm press release, Endo International plc provides specialty healthcare solutions. The Company develops, manufactures, markets, and distributes pharmaceutical products and generic drugs. Endo International offers its products to the medical and healthcare industries around the globe.

On September 28, 2015, Endo announced that it had completed its $8.05 billion acquisition of Par Pharmaceutical Holdings, Inc. (“Par Pharmaceutical”) from the private investment firm TPG (the “Par Pharmaceutical Acquisition”). Par Pharmaceutical Companies Inc. is a manufacturer and distributor of generic drugs and operates as a subsidiary of Par Pharmaceutical.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Par Pharmaceutical had colluded with several of its industry peers to fix generic drug prices; (ii) the foregoing conduct constituted a violation of federal antitrust laws; (iii) the competitive advantages of the Par Pharmaceutical Acquisition, which Endo touted to its shareholders as, inter alia, “a compelling opportunity to drive future double-digit growth, serve our customers and build shareholder value,” were in fact derived in part from Par Pharmaceutical’s illegal conduct and thus unsustainable; (iv) for the same reasons, the “impressive track record of delivering strong operating results” that Endo attributed to former Par Pharmaceutical executive Paul Campanelli in announcing his promotion to Endo’s CEO consisted in part of illegal conduct; (v) for the foregoing reasons, Endo’s revenues during the Class Period were in part the result of illegal conduct and likewise unsustainable; and (vi) as a result of the foregoing, Endo’s public statements were materially false and misleading at all relevant times.

On June 19, 2018, the Court issued an Order appointing Lead Plaintiff and Counsel. Lead Plaintiff filed an amended Complaint on August 6. Defendants filed a Motion to Dismiss the amended Complaint on September 14. On February 14, 2020, the Court issued an Order granting in part and denying in part Defendants' Motion to Dismiss.


Sector: Healthcare
Industry: Major Drugs
Headquarters: Ireland


Ticker Symbol: ENDP
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: E.D. Pennsylvania
DOCKET #: 17-CV-05114
JUDGE: Hon. John R. Padova
DATE FILED: 11/14/2017
CLASS PERIOD END: 02/28/2017
  1. Pomerantz LLP (New York)
  2. Pribanic & Pribanic
No Document Title Filing Date
COURT: E.D. Pennsylvania
DOCKET #: 17-CV-05114
JUDGE: Hon. John R. Padova
DATE FILED: 08/06/2018
CLASS PERIOD END: 02/27/2017
  1. Bleichmar Fonti & Auld LLP
    7 Times Square, 27th Floor, Bleichmar Fonti & Auld LLP, NY 10036
    212.789.1340 ·
  2. Elliott Greenleaf, P.C.
    925 Harvest Drive, Suite 300, Elliott Greenleaf, P.C., PA 19422
    215.977.1000 215.977.1099 ·
  3. Kehoe Law Firm, P.C.
    Two Penn Center Plaza 1500 JFK Boulevard, Suite 1020, Kehoe Law Firm, P.C., PA 19102
    (215) 792-6676 ·
No Document Title Filing Date
—Related District Court Filings Data is not available